Another J&J defective hip replacement recalled

During these unprecedented times, Clark, Perdue, & List Co, LPA is here to fully support your needs in a timely and safe manner. COVID-19 should not affect your ability to investigate a personal injury case. We currently remain open and are still accepting new cases. With your safety top of mind, we are scheduling all meetings via telephone or video conference at this time.

Johnson & Johnson has alerted doctors in 21 countries to stop using their Adept hip implant, as the defective hip replacement has a higher than average failure rate.

A British database reported that as many as 12 percent of Adept recipients required additional surgeries to correct problems and injuries associated with the implants. Approximately 7,500 Adept hip implants were sold worldwide prior to 2011. None of the implants were distributed in the United States.

Johnson and Johnson is the world’s largest manufacturer of health care products. In August 2010, the company recalled 93,000 DePuy ASR hip implants. Approximately 10,000 lawsuits regarding those implants have been filed and are currently being litigated in federal court. Plaintiffs complain of pain, joint dislocations, infection, fractures and high levels of cobalt and chromium in the body. Like the ASR implants, the Adept implants are metal-on-metal devices.

Johnson & Johnson acquired the Adept hip implant from U.S. manufacturer Finsbury Orthopaedics Ltd. in 2009.

For more information, contact the Ohio defective hip replacement attorneys at Clark, Perdue & List.

Source: Bloomberg, “J&J Warns of Safety Risk for 7,500 Non-U.S. Hip Implants,” Shannon Pettypiece & Michelle Fay Cortez, February 15, 2013.